These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 22463608

  • 1. Phospholamban and cardiac function: a comparative perspective in vertebrates.
    Cerra MC, Imbrogno S.
    Acta Physiol (Oxf); 2012 May; 205(1):9-25. PubMed ID: 22463608
    [Abstract] [Full Text] [Related]

  • 2. Role of phospholamban phosphorylation on Thr17 in cardiac physiological and pathological conditions.
    Mattiazzi A, Mundiña-Weilenmann C, Guoxiang C, Vittone L, Kranias E.
    Cardiovasc Res; 2005 Dec 01; 68(3):366-75. PubMed ID: 16226237
    [Abstract] [Full Text] [Related]

  • 3. Frequency-dependent acceleration of relaxation in mammalian heart: a property not relying on phospholamban and SERCA2a phosphorylation.
    Valverde CA, Mundiña-Weilenmann C, Said M, Ferrero P, Vittone L, Salas M, Palomeque J, Petroff MV, Mattiazzi A.
    J Physiol; 2005 Feb 01; 562(Pt 3):801-13. PubMed ID: 15528241
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The importance of the Thr17 residue of phospholamban as a phosphorylation site under physiological and pathological conditions.
    Mattiazzi A, Mundiña-Weilenmann C, Vittone L, Said M, Kranias EG.
    Braz J Med Biol Res; 2006 May 01; 39(5):563-72. PubMed ID: 16648892
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.
    Schmitt JP, Ahmad F, Lorenz K, Hein L, Schulz S, Asahi M, Maclennan DH, Seidman CE, Seidman JG, Lohse MJ.
    Circulation; 2009 Jan 27; 119(3):436-44. PubMed ID: 19139388
    [Abstract] [Full Text] [Related]

  • 10. Phospholamban phosphorylation by CaMKII under pathophysiological conditions.
    Vittone L, Mundina-Weilenmann C, Mattiazzi A.
    Front Biosci; 2008 May 01; 13():5988-6005. PubMed ID: 18508637
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
    Neumann J, Boknik P, DePaoli-Roach AA, Field LJ, Rockman HA, Kobayashi YM, Kelley JS, Jones LR.
    J Mol Cell Cardiol; 1998 Oct 01; 30(10):1991-2002. PubMed ID: 9799653
    [Abstract] [Full Text] [Related]

  • 14. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
    Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM.
    Circ Res; 2005 Dec 09; 97(12):1314-22. PubMed ID: 16269653
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Improving cardiac Ca⁺² transport into the sarcoplasmic reticulum in heart failure: lessons from the ubiquitous SERCA2b Ca⁺² pump.
    Vangheluwe P, Wuytack F.
    Biochem Soc Trans; 2011 Jun 09; 39(3):781-7. PubMed ID: 21599649
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of phospholamban phosphorylation by O-GlcNAcylation: implications for diabetic cardiomyopathy.
    Yokoe S, Asahi M, Takeda T, Otsu K, Taniguchi N, Miyoshi E, Suzuki K.
    Glycobiology; 2010 Oct 09; 20(10):1217-26. PubMed ID: 20484118
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.